MedTech Terms
    The authoritative reference
    All terms
    Quality & RiskQuality System

    Shelf Life

    Period during which a device remains suitable for its intended use under specified conditions.

    Reviewed by Christian Espinosa, Founder, Blue Goat CyberLast reviewed May 5, 2026

    Definition

    Shelf life is supported by accelerated aging and real-time aging studies, often per ASTM F1980, that demonstrate package integrity and product performance over time.
    What the regulation says
    Under the U.S. FDA, shelf life testing is critical for demonstrating that a medical device maintains its safety and effectiveness over its stated lifetime, as required by 21 CFR 820.30, Design Control. The EU MDR, in Annex I, General Safety and Performance Requirements, similarly mandates that devices be designed and manufactured in a way that they remain safe and perform as intended throughout their foreseen lifetime, including stability and storage conditions. ISO 13485:2016, clause 7.5.1, Production and service provision, also requires documented procedures for controlling product realization, which implicitly includes shelf life considerations for product quality.

    What this means in practice

    Shelf-life claims appear in labeling and must be supported by valid data. Extension studies are common as real-time data accumulates.

    Examples

    • A manufacturer performs accelerated aging on a new sterile catheter package to support a preliminary 3-year shelf life claim, while simultaneously initiating real-time aging studies.
    • A company submits data from ongoing 5-year real-time aging studies to the FDA to extend the shelf life of their implantable device from 3 years to 5 years.
    • During a design change to a drug-eluting stent, the manufacturer conducts new accelerated and real-time aging studies to ensure the drug elution profile and stent integrity are maintained over the original shelf life.
    Common pitfalls
    • •A common pitfall is relying solely on accelerated aging data without initiating or completing real-time aging studies, which are crucial for conclusive shelf life determination.
    • •Manufacturers sometimes fail to consider the impact of packaging degradation on device sterility or functionality throughout the claimed shelf life.
    • •Another mistake is not establishing a clear, scientifically sound justification for the chosen accelerated aging conditions, potentially leading to invalid shelf life claims.
    • •Inadequate sample sizes for aging studies can lead to statistically unreliable data, making it difficult to defend shelf life claims during regulatory audits.
    • •Failing to re-evaluate shelf life after design changes or material substitutions can result in non-compliant products on the market.

    Frequently asked questions

    Shelf life ensures that a medical device remains safe, effective, and performs as intended from its manufacturing date until the end of its designated period, guarding against degradation of materials, functionality, or sterility.
    Grouped by theme

    Mentioned in recent activity

    10 entries

    Latest in MedTech

    View all

    Recent regulatory actions, publications, and trials matched to this term. Updated daily.

    Primary references

    3 sources
    Link health: 3 verified· last checked 2026-06-20
    ASTM·1MDIC·1FDA·1
    1. 1
      ASTM F1980
      Verified
      ASTMastm.org
    2. 2
      MDIC Case for Quality
      Verified
      MDICmdic.org
    3. 3
      FDA - Quality Systems
      Verified
      FDAfda.gov

    Inline markers like [1] jump to the matching reference above.